About US
Contact us
-
German Merck is among the companies fishing in Iran for more businessPharmaceuticals are among the small number of products that Western companies can still sell to Iran under the sanctions program designed to deter its nuclear ambitions. The process, however, is compl2013/12/30
-
GSK obtains European approval for Cervarix two-dose scheduleGlaxoSmithKline (GSK) has received marketing authorisation from the European Commission for its cervical cancer vaccine Cervarix as a two-dose schedule for girls aged nine to 14 years. Cervarix [Huma2013/12/27
-
Roche's rheumatoid arthritis drug RoACTEMRA gets CHMP positive opinionRoche has received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its subcutaneous formulation of RoACTEMRA (tocilizumab) to treat mode2013/12/27
-
PHEXCOM has sponsored and joined in the celebration for the elderly people in GuangQi Nursing House together with over 80 volunteers on 21th Dec, 2013Currently around 100 elderly people lived in Guangqi Nursing House and they are aged from 70 years old to 101 years old. Basically 3-4 people are living in one room. Most of them have religions of Cat2013/12/26
-
ATMI Announces Agreement to Sell LifeScienc​es Business to Pall Corporatio​nATMI, Inc., a global technology company and leader in single-use bioprocess solutions, has reached agreement with Pall Corporation to sell ATMI LifeSciences in a transaction valued at $185 million.2013/12/26
-
Novo gets a year-end win for Factor XIII blood-clotting product after two rejectionsThree's a charm for Novo Nordisk ($NVO) and its recombinant Factor XIII compound for a rare bleeding disorder. After receiving a complete response letter (CRL) in 2012 and then again this August, the2013/12/26
-
FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia A&B patients with inhibitorsThe US Food and Drug Administration (FDA) has approved Baxter's FEIBA [anti-inhibitor coagulant complex] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A2013/12/25
-
FDA Approves Tretten to Treat Rare Genetic Clotting Disorder‏FDA hasapproved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in the routine prevention of bleeding in adults and children who have a rare clotting di2013/12/25
-
Takeda acquires exclusive rights to develop Natrogen's anti-inflammatory compoundTakeda Pharmaceutical has entered into an exclusive licence and option agreement with Natrogen Therapeutics International. The licensing is for the development of Natrogen's Natura-alpha compound for2013/12/24
-
FDA Requires Multiple New Safety Measures for Leukemia Drug Iclusig; Company Expected to Resume Marketing‏FDA is requiring several new safety measures for the leukemia drug Iclusig (ponatinib) to address the risk of life-threatening blood clots and severe narrowing of blood vessels. Once these new safety2013/12/24